Latest Breaking News On - Burkhard blank - Page 1 : comparemela.com

MannKind (MNKD) Q2 2023 Earnings Call Transcript

MNKD earnings call for the period ending June 30, 2023.

United statesNew yorkNorth carolinaSteven lichtmanAfrezza trxThomas smith leerinkOlivia brayerSteven lichtman oppenheimerSteve binderAnthony petrone mizuhoThomas smithGregory renzaOren livnatMichael castagnaAsia pacificOlivia brayer cantor fitzgerald

Dr Gilbert Wagener brings to Pharnext 30 years of experience in medical affairs and R&D in various therapeutic areas, including neurological and/or rare diseases, and on products at various. | June 15, 2023

United statesFrance generalFabreguettes leibGenzyme europeGilbert wagenerHugo brugiGerman society of physiologyEuronext growth stock exchangeErasmus universityMarburg university hospitalsEuropean society of cardiologyRegenerative medicine advisory committeeGerman society of pharmacologyEpidemiology public healthUniversity of baselEuropean society of hypertension

PHARNEXT: Pharnext appoints Gilbert Wagener, M D , Ph D as Chief Medical Officer

PHARNEXT: Pharnext appoints Gilbert Wagener, M D , Ph D as Chief Medical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalGilbert wagenerHugo brugiGenzyme europeFabreguettes leibGerman society of pharmacologyUniversity of baselEuronext growth stock exchangeEuropean society of hypertensionSenior partner at transcrip partnersEuropean society of cardiologyMarburg university hospitalsErasmus universityGerman society of physiologyEpidemiology public health

Recent Digital Health Executive Hires & Board Appointments

Roundup summary of recent digital health executive hires from Practice Better, HHAeXch, Intelerad Medical Systems, Cynerio, Tegria..

Nicole kerkenbushMichael yooMarc rabnerZyter trucareNancy bealeJoanne berriosDoug klingerTalis bioAaron greenMichael castagnaKim walshJen morganBillie jo nutterSusan heichertBurley wrightHeiner dreismann

Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial

Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMary jane elliottAlexandra harrisonSukaina virjiXavier paoliGhislaine gasparettoEuronext growth stock exchangeMedia relations internationalConsilium strategic communicationsLabel extensionOverall neuropathy limitations scaleBurkhard blankChief medical officerChief operating officerCharcot marie tooth disease type